期刊文献+

玉米醇溶蛋白-肝素微球的制备和缓释 被引量:4

The Preparation and the Release Kinetics of Zein-Heparin Microspheres
暂未订购
导出
摘要 为了开发一种stent涂层材料,使其具有一定的肝素缓释效果,以期对stenting技术中急性血栓形成的预防有所助益,通过对玉_米醇溶蛋白-肝素微球的制备方法、微球粒径控制、体外肝素的释放动力学等方面进行了系统研究,结果表明:玉米醇溶蛋白、肝素微球粒径可控,并具有一定的缓释效果。 The purpose was to develop a coating material encapsulating heparin, which could be sustainedly released. The preparation, the size, and the release kinetics of zein-heparin microspheres were studied, The results show that the size of zein-heparin microspheres could be controlled and 80% of heparin is released after two days.
出处 《科学技术与工程》 2003年第6期557-560,共4页 Science Technology and Engineering
基金 国家重大科研项目863计划(2002AA327100)
  • 相关文献

参考文献26

  • 1[1]Gentry P W, Alexander B. Specific coagulation factor adsorption to insoluble heparin. Biochem Biophys Res Commun, 1973;50:500-508
  • 2[2]Hommes D, et al. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis.Ann Intern Med, 1992;116:279-284
  • 3[3]Iaskey M A, et al. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcomes in patients with unstable angina. Am J Cardiol,1990;65(22): 1425-1429
  • 4[4]Theroux P, et al. Reactivation of unstable angina after discontinuation of heparin. N Engl J Med, 1992;327:141-145
  • 5[5]Scati T. (Studio sulla Calciparina nell ' Angina e nella Thrombosi Ventricolare nell' Infarto) Group, Randomized controlled trial of subcutaneous calciumheparin in acute myocardial infarction. Lancet, 1989;2:182-186
  • 6[6]Hettleman B D, et al. Three days of heparin pretreatment reduces major complications of coronary angioplasty in patients with unstable angina. J Am Coll Cardiol, 1990; 15(2): 154A
  • 7[7]Edelman E R, Nathan A, Katada M, Gates J, Karnovsky M J. Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21:2279-2286
  • 8[8]Fischman D L, Leon M B, Baim D S, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med, 1994;331:496-501
  • 9[9]Lau K W, Sigwart U. Restenosis an accelerated arterioparthy: pathophysiology, preventive strategies and research horizons. In: ed. Edelman E R. Molecular interventions and local drug delivery. Philadelphia: W B Saunders, 1995:1-28
  • 10[10]Rogers C, Edlman E R, Endovascular stent design dictates experimental restenosis and thrombosis. Circulation, 1995;91:2995-3001

同被引文献43

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部